The Peer’s lab works at the interface of materials science, chemistry, molecular biology, and immunology, to discover and validate novel therapeutic targets at the molecular level, and to develop specific genetic medicines for therapeutics and disease management.
The lab is highly dynamic, multi-disciplinary, and focuses on developing targeted vehicles for cell-specific delivery of novel molecular medicines using RNAi, mRNA, saRNA, cirRNA, DNA, and novel genome editing strategies. The lab goal is to translate academic discoveries into innovative therapeutic modalities.